Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5279066
Max Phase: Preclinical
Molecular Formula: C24H21N5S
Molecular Weight: 411.53
Associated Items:
ID: ALA5279066
Max Phase: Preclinical
Molecular Formula: C24H21N5S
Molecular Weight: 411.53
Associated Items:
Canonical SMILES: Cc1ccccc1-n1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1
Standard InChI: InChI=1S/C24H21N5S/c1-17-6-2-5-9-22(17)29-23(18-10-13-25-14-11-18)27-28-24(29)30-15-12-19-16-26-21-8-4-3-7-20(19)21/h2-11,13-14,16,26H,12,15H2,1H3
Standard InChI Key: UYEMTNLGTODWQB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 411.53 | Molecular Weight (Monoisotopic): 411.1518 | AlogP: 5.45 | #Rotatable Bonds: 6 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 3.71 | CX LogP: 5.42 | CX LogD: 5.42 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.38 | Np Likeness Score: -1.64 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):